勃林格殷格翰

勃林格殷格翰

制药业

Ingelheim am Rhein,Rhineland-Palatinate 1,892,697 位关注者

关于我们

Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint

网站
http://www.boehringer-ingelheim.com
所属行业
制药业
规模
超过 10,001 人
总部
Ingelheim am Rhein,Rhineland-Palatinate
类型
私人持股
领域
Pharmaceuticals、Animal Health、Innovation、Research、Health Care、Improve Health、Biopharmaceuticals和Contract Manufacturing

地点

  • 主要

    Binger Straße

    DE,Rhineland-Palatinate,Ingelheim am Rhein,55218

    获取路线
  • 813, Cours du 3ème Millénaire

    FR,Auvergne-Rhône-Alpes,Saint-Priest,69800

    获取路线
  • 900 Ridgebury Rd

    US,CT,Ridgefield,06877

    获取路线
  • Birkendorfer Straße 65

    DE,Baden-Württemberg,Biberach an der Riß,88400

    获取路线
  • Eski Buyukdere Caddesi

    Uso Center No: 245 Kat 9,13,14,16

    TR,Istanbul,34398

    获取路线
  • Ellesfield Avenue

    GB,Berkshire,Bracknell,RG12 8YS

    获取路线
  • The Hyde Building 4th Floor

    The Park Carrickmines

    IE,Dublin,Dublin 18

    获取路线
  • 5180 S Service Rd

    CA,ON,Burlington,L7L 5H4

    获取路线
  • 3239 Satellite Blvd NW

    US,GA,Duluth,30096

    获取路线
  • 300 Beach Rd

    SG,Singapore,Singapore,199555

    获取路线
  • Rodovia Regis Bittencourt

    BR,SP,Itapecerica da Serra,06850-840

    获取路线
  • Avenida Carrera 11 84-9

    CO,Bogota, D.C.,Bogota,110221

    获取路线
  • Comeniusstraat 6

    NL,North Holland,Alkmaar,1817

    获取路线
  • De Boelelaan 32

    NL,North Holland,Amsterdam,1083

    获取路线
  • Leof. Andrea Syngrou 340

    GR,Attica,Kallithea,176 73

    获取路线
  • Avenida de Pádua

    PT,Lisbon,Lisbon,1800-294

    获取路线
  • Avenue Ariane

    BE,Brussels Region,St-Lambrechts-Woluwe,1200

    获取路线
  • Strødamvej 52

    DK,Capital Region,Copenhagen,2100

    获取路线
  • Tammasaarenkatu 5

    FI,Southern Finland,Helsinki,00180

    获取路线
  • Hagaløkkveien 26

    NO,Akershus,Asker,1383

    获取路线
  • Hammarby allé 29

    SE,Stockholm County,Stockholm,120 61

    获取路线
  • 100-104, Avenue de France

    FR,Île-de-France,Paris,75013

    获取路线
  • 4, Rue Pierre Hadot

    FR,Grand Est,Reims,51100

    获取路线
  • 29, Avenue Tony Garnier

    FR,Auvergne-Rhône-Alpes,Lyon,69007

    获取路线
  • 4, Chemin du Calquet

    FR,Occitanie,Toulouse,31100

    获取路线
  • 805, Allée des Cyprès

    FR,Auvergne-Rhône-Alpes,Saint-Vulbas,01150

    获取路线
  • 1, Chemin de Cruzols

    FR,Auvergne-Rhône-Alpes,Lentilly,69210

    获取路线
  • Dr. Boehringer-Gasse 5-11

    AT,Vienna,1120

    获取路线
  • 6701 Kaiser Dr

    US,California,Fremont,94555

    获取路线
  • Pudong New Area

    CN,Shanghai,201203

    获取路线

勃林格殷格翰员工

动态

  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    #NEWS: There is an urgent need for additional targeted therapies for people living with hard-to-treat cancers, which are associated with a poor prognosis. We are pleased to announce that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to our HER2 mutation targeting investigational treatment for certain hard-to-treat types of lung cancer. This designation is given to medicines for rare diseases, promoting quicker development and streamlined approval to ensure new medicines can get to patients as quickly as possible. Learn more about our commitment to lung cancer: https://lnkd.in/eJksrN99

    • 该图片无替代文字
  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    We've covered a lot of ground this past year. The urgency to address unmet human, animal and societal needs by solving complex healthcare challenges has led to innovations that inspire hope for a better tomorrow.   Just as important are the connections we have made along the way. Those moments we have shared with one another kept us moving, shifting our perspectives, and helping us to understand what it truly takes to move forward.   We now look to a new year, to a future where humans and animals will live longer, healthier lives. A future where we focus on the ways we – and the world around us – are interconnected.    We are grateful for our colleagues, patients, animals, partners and healthcare providers and look forward to continuing this journey together. Wishing everyone a happy, healthy and hopeful holiday season.

  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    Data-related skills are becoming increasingly important. But have you ever thought about how you can prepare for the era of #data and #AI? We have! That's why we support our employees with qualitative, flexible, and interactive trainings. Developed by our data experts, our new Data X Academy offers various learning opportunities: from data science, data analytics and data engineering to data governance. This offer is aimed at all employees – from beginners to experts and even leadership teams. Interested? 🤔 Become part of our team: https://lnkd.in/guZFjt7u

  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    We want to transfrom the lives of patients with new therapies. One example are viral therapeutics. With our partners from the BioPharma Cluster South Germany we discussed how we can bring them as quickly as possible to the patients. We showed how we manufacture viral therapies on scale at our site in Ochsenhausen. Curious to learn more about our pipeline? Then check out the following link: https://lnkd.in/e-SAPB3u #LifeForward #Innovation #Biopharmaceuticals

    查看BioPharma Cluster South Germany的公司主页,图片

    3,367 位关注者

    𝐅𝐥𝐚𝐬𝐡𝐛𝐚𝐜𝐤 – 𝐕𝐢𝐫𝐮𝐬 𝐛𝐚𝐬𝐞𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬  Novel virus-based therapies were the subject of last week`s conference in Ulm organized in collaboration with GBM - Gesellschaft für Biochemie und Molekularbiologie e.V. The meeting welcomed about 150 participants and covered the entire spectrum from basic research and industrial application to clinical translation. The industrial perspective started with a keynote from Prof. Wolfram Carius (Bayer), who delivered an overview of the existing opportunities and challenges for cell- and gene therapies on a global scale and general trends in the current industrial environment. After his presentation, different experts from the pharmaceutical industry and applied research institutions shared specific case studies, addressing different aspects of early development, manufacturing and clinical translation of virus based therapeutics. 👉 Dr. Jan Schöning discussed the art and science of manufacturing viral therapeutics at the Boehringer Ingelheim site in Biberach and Ochsenhausen. 👉 Prof. Dr. Susanne Bailer presented the newly established branch of the Fraunhofer Institute for Interfacial Engineering and Biotechnology on virus-based therapies at the ITZ Plus in Biberach. 👉 Dr. Robert Panting from Rentschler Biopharma provided insights into a high-throughput approach for improved manufacturability of adeno-associated vectors (AAVs). 👉 Last but not least, Dr. Kai Lipinski (ReciBioPharm) shared his knowledge about the challenges and considerations to bring adenovirus-based oncolytic therapeutics to the clinic successfully. A big shout out to all speakers of the session who contributed so much to the overall success of the event 👏 It has been a pleasure to work with you and host all of you last Friday. But as a well-known German proverb says: ‘After one trade fair is before the next.’ So you can already mark the 4th edition of the event focusing on ‘AI/Digital (r)evolution in Drug Development and Manufacturing’ in your calendar. 🔩 𝐍𝐮𝐭𝐬 & 𝐁𝐨𝐥𝐭𝐬 𝐃𝐚𝐭𝐞: 5th of December 2025 𝐓𝐢𝐦𝐞: 1 – 8.30 pm 𝐕𝐞𝐧𝐮𝐞: Stadthaus Ulm #Biopharmaceuticals #NewModalities #Therapeutics #Research #ClinicalTranslation #BestPractices #Medicine #LifeScience #GBM #BPCluster Sartorius | Teva Pharmaceuticals | Vetter Pharma | Fachhochschule Biberach | Ulm University

    • 该图片无替代文字
  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    Collaborations between academia and industry can lead to new therapies for patients. Our opnMe colleagues were awarded with the best 2024 Practice Award at the Annual World Open Innovation Conference (WOIC) . Do you want to meet the team and learn more how you can collaborate with us? Then join us at our Heidelberg #TransformingScienceDay either in person or virtually: https://lnkd.in/eCy_-83H #LifeForward #Innovation

    查看opnMe的公司主页,图片

    954 位关注者

    #opnMe has won the 2024 Best Practice Award at the World Open Innovation Community's (WOIC) 11th Annual Conference at the University of California, Berkeley by receiving the majority votes from both the audience and the jury. Marcel Bogers, WOIC conference chair, and Ruperto Calatrava, Industry Track Lead at WOIC, stated, "opnMe stood out for its exceptional originality, fostering groundbreaking collaboration between academia and industry to tackle challenges in life sciences. It demonstrated remarkable results, with significant research outputs and global impact, serving as a model for the broader open innovation community". Learn more in the accompanying news article: https://lnkd.in/espTQTtZ

    • Picture of the 2024 participants of the 11th annual World Open Innovation Conference (WOIC) with the call out: “Best Practice award for opnMe”
  • 查看勃林格殷格翰的公司主页,图片

    1,892,697 位关注者

    Did you know that calves are extremely vulnerable in the first hours and days after birth🐮? Their immune system is not yet fully developed, which is why veterinarians and farmers need to take extra care to give them a good start in life.   Our calfXpert OPTIMAX Award connects vets with farmers to raise awareness and drive efficiency. Meet the winners Rebecca Price, Martha Twist and Esperanza Rodriguez. Their case studies showcased practical solutions to key calf rearing challenges, like calf diarrhea, through close collaboration with farmers, leading to measurable improvements in calf health and well-being.  #Farmers and #veterinarians, have you worked with our calfXpert OPTIMAX management framework yet? Contact your Boehringer representative if you'd like to learn more. #LifeForward

    • 该图片无替代文字

相似主页